Recent statistics show that as of a few years ago, FDA approval rates for Phase 3 clinical trial drugs were in excess of 60%, which is an improvement over historical levels. And the approval rates are probably a bit higher now.

I didn't keep the link but anyone who is really interested can probably google to find the article.